BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22213321)

  • 1. C15-functionalized 16-ene-1α,25-dihydroxyvitamin D3 is a new vitamin D analog with unique biological properties.
    Kumagai G; Takano M; Shindo K; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Takimoto-Kamimura M; Takenouchi K; Chen TC; Kittaka A
    Anticancer Res; 2012 Jan; 32(1):311-7. PubMed ID: 22213321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of 2α-(tetrazolylethyl)-1α,25-dihydroxyvitamin D3 as a high affinity ligand for vitamin D receptor.
    Matsuo M; Hasegawa A; Takano M; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Takenouchi K; Sawada D; Kittaka A
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():201-3. PubMed ID: 24036313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D(3) A-ring analog with significant transactivation activity.
    Mikami K; Ohba S; Ohmura H; Kubodera N; Nakagawa K; Okano T
    Chirality; 2001 Jul; 13(7):366-71. PubMed ID: 11400190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
    Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
    Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
    Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
    J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
    Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
    J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
    Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
    Collins ED; Bishop JE; Bula CM; Acevedo A; Okamura WH; Norman AW
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):279-88. PubMed ID: 15857747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of 1α,2α,25-trihydroxyvitamin D3: active metabolite of 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 by human CYP3A4.
    Takano M; Ohya S; Yasuda K; Nishikawa M; Takeuchi A; Sawada D; Sakaki T; Kittaka A
    Chem Pharm Bull (Tokyo); 2014; 62(2):182-4. PubMed ID: 24492588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
    Zhou X; Zhu GD; Van Haver D; Vandewalle M; De Clercq PJ; Verstuyf A; Bouillon R
    J Med Chem; 1999 Sep; 42(18):3539-56. PubMed ID: 10479287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential recruitment of coactivators to the vitamin D receptor transcriptional complex by 1alpha,25-dihydroxyvitamin D3 analogs.
    Schwinn MK; DeLuca HF
    Arch Biochem Biophys; 2007 Sep; 465(2):443-51. PubMed ID: 17658451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
    Bouillon R; Sarandeses LA; Allewaert K; Zhao J; Mascareñas JL; Mouriño A; Vrielynck S; de Clercq P; Vandewalle M
    J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
    Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3).
    Takayama H; Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Smith C; DeLuca HF; Nakagawa K; Kurobe M; Okano T
    Steroids; 2001; 66(3-5):277-85. PubMed ID: 11179735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.
    Kittaka A; Hara H; Takano M; Sawada D; Arai MA; Takagi K; Chida T; Harada Y; Saito H; Takenouchi K; Ishizuka S; Hayashi K; Ikushiro S; Sakaki T; Sugiura T; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3563-9. PubMed ID: 19667149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.